Covered recipient · General Payments record
ROSS A PARKS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$5,941.05
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,603.92 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $419.08 | 6 |
| ABBVIE INC. | $394.98 | 14 |
| GLAUKOS CORPORATION | $270.27 | 2 |
| Apellis Pharmaceuticals, Inc. | $121.82 | 1 |
| Dompe US, Inc. | $119.46 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $111.14 | 1 |
| Harrow Eye, LLC | $62.93 | 3 |
| Oyster Point Pharma, Inc. | $36.97 | 2 |
| Bausch & Lomb Americas Inc. | $35.75 | 2 |
| Mallinckrodt Hospital Products Inc. | $31.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.49 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185362 | CMS |
| ABBVIE INC. | $124.97 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185364 | CMS |
| ABBVIE INC. | $24.54 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185366 | CMS |
| ABBVIE INC. | $20.79 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185368 | CMS |
| ABBVIE INC. | $22.59 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185370 | CMS |
| ABBVIE INC. | $32.40 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185372 | CMS |
| ABBVIE INC. | $21.93 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185374 | CMS |
| ABBVIE INC. | $19.04 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185376 | CMS |
| ABBVIE INC. | $15.24 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185378 | CMS |
| ABBVIE INC. | $31.33 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185380 | CMS |
| ABBVIE INC. | $20.30 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185382 | CMS |
| ABBVIE INC. | $11.86 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185384 | CMS |
| ABBVIE INC. | $13.50 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185386 | CMS |
| ABBVIE INC. | $33.00 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105185388 | CMS |
| Alcon Vision LLC | $104.13 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110586099 | CMS |
| Alcon Vision LLC | $10.67 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110586093 | CMS |
| Alcon Vision LLC | $22.70 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110586097 | CMS |
| Alcon Vision LLC | $132.47 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110588611 | CMS |
| Alcon Vision LLC | $16.98 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110586095 | CMS |
| Alcon Vision LLC | $132.13 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110588609 | CMS |
| Apellis Pharmaceuticals, Inc. | $121.82 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154028891 | CMS |
| Bausch & Lomb Americas Inc. | $14.29 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140438764 | CMS |
| Bausch & Lomb Americas Inc. | $21.46 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140438766 | CMS |
| Dompe US, Inc. | $93.09 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151414769 | CMS |
| Dompe US, Inc. | $26.37 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151414771 | CMS |
| Glaukos Corporation | $118.66 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151988462 | CMS |
| Glaukos Corporation | $151.61 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151988464 | CMS |
| Harrow Eye, LLC | $21.64 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145611659 | CMS |
| Harrow Eye, LLC | $20.43 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145611661 | CMS |
| Harrow Eye, LLC | $20.86 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145611663 | CMS |
| Mallinckrodt Hospital Products Inc. | $31.52 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145117488 | CMS |
| Oyster Point Pharma, Inc. | $18.38 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147424543 | CMS |
| Oyster Point Pharma, Inc. | $18.59 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147413974 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $111.14 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152197473 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.